Second Colombian Consensus on the Management of Post-menopausal Osteoporosis: 2017 update

Orjuela, Adriana Medina; Olarte, O.; Plata, Pedro Nel Rueda; Escobar, Fabio Sánchez; Choueka, Monique Chalem; Reyes, Miguel; González, Alejandro Román; Lozano, Alexandra; Talero, Amanda Páez; Belt, Camilo Rueda; Barrera, Carlos Alfonso Builes; Niño, Carlos Augusto Pérez; Fernández-Ávila, Daniel G.; Awad, David Vásquez; Devia, Deyanira González; Pabón, Edgar Pinilla; Valdivieso, Eduardo; Mejía, Esdras Martín Vásquez; Grajales, Francisco Iván Vargas; Restrepo, Francisco Linares; Canales, Geraldine Altamar; Uribe, Gustavo Adolfo Molina; Acero, Gustavo Adolfo Pineda; Quintero, Henry Mauricio Arenas; Patiño, Jorge Augusto Vélez; Restrepo, José Fernando Molina; Raad, Juan José Jaller; Gutiérrez, Ricardo Londoño; Coordinators, Annex; Clark, Patricia; Angulo, orlando; Castaño, Carlos Federico Molina

doi:10.1016/j.rcreue.2019.01.004

Cited by 2 publications

(3 citation statements)

References 165 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

Section: Introductionmentioning

confidence: 99%

“…Therapeutic failure was considered when a patient who has been adhering to the prescribed management plan has two or more new fragility fractures during the first 12 months after starting treatment, or 1 or more new fragility fractures beyond those first 12 months. 13 The timely start and adherence to the established management are recorded in the follow up that each patient has after surgery. In those patients who cannot attend a consultation or receive a home visit, follow-up is done by telephone at 3, 6, and 12 months postoperatively.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Impact of a Secondary Prevention Program for Fragility Fractures at the Orthogeriatric Clinical Care Center at the Fundación Santa Fe de Bogotá, 2014-2020

Olarte

López

Feldman

et al. 2022

Geriatr Orthop Surg Rehabil

View full text Add to dashboard Cite

Introduction: The presence of a fragility fracture increases the risk of new fractures. The timely and prompt initiation of treatment for osteoporosis can reduce the incidence of new fractures, for which adherence to management is a determining factor. The main objective of the study was to characterize the secondary prevention program for fragility hip fractures in patients older than 65 years, determine adherence to treatment and its effect on the appearance of new fractures in the established follow-up period. Materials and Methods: A descriptive retrospective cohort study was carried out. Patients older than 65 years with a fragility hip fracture treated by an Orthogeriatric Clinical Care Center between May 2014 and April 2020 who completed a one-year follow-up were included. Results: A final sample of 290 patients was obtained (226 women and 64 men) with an average age of 82.27 years. It was found that 84.5% of patients received indications to start osteoporotic management prior to hospital discharge and only 35.2% started the treatment in the first 6 postoperative months. 16.6% (n = 48) of patients presented a new fracture, with no significant difference between those who started their osteoporosis treatment in a timely manner. Out of the 48 patients, 5 patients (10.4%) met therapeutic failure criteria. Discussion: Most patients (84.5%) received indications for starting osteoporotic treatment before hospital discharge, nevertheless 35.2% started it during the first 6 postoperative months. 16.6% of patients presented a new fracture during follow up, of which only five met therapeutic failure criteria. Conclusions: No significant differences were found between the presence of new fractures and early initiation of osteoporotic management. However, literature shows that prompt and timely osteoporotic treatment reduces the incidence of new fractures, thus measures must be implemented to strengthen the adherence and surveillance of patients to the indicated treatment.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Impact of a Secondary Prevention Program for Fragility Fractures at the Orthogeriatric Clinical Care Center at the Fundación Santa Fe de Bogotá, 2014-2020

Olarte

López

Feldman

et al. 2022

Geriatr Orthop Surg Rehabil

View full text Add to dashboard Cite

show abstract

“…La osteosarcopenia es un síndrome que se ha definido desde hace varios años como la presencia de dos entidades prevalentes en la población adulta mayor: baja masa mineral ósea, entendida como osteopenia/osteoporosis, y sarcopenia. La osteopenia/osteoporosis es una enfermedad ósea sistémica donde se altera la microarquitectura ósea y se reduce la densidad mineral ósea (DMO), aumentando la fragilidad ósea y predisponiendo al riesgo de fracturas (1,2). La diferencia entre osteopenia y osteoporosis se basa principalmente en los resultados de la DMO, en la que los sujetos se consideran con osteopenia si la DMO se encuentra entre -1 y -2,5 DE, mientras que la DMO menor a -2,5 DE se considera osteoporosis (1).…”

Section: Introductionunclassified

Osteosarcopenia en adultos mayores

Galindo

Venegas-Sanabria

Martínez

et al. 2022

Rev.ACE

View full text Add to dashboard Cite

Contexto: La osteosarcopenia es un nuevo síndrome geriátrico con graves consecuencias en el anciano. Se ha descrito su relación con el riesgo de caídas, fracturas, dependencia funcional y mortalidad. Se define como la coexistencia de baja masa mineral ósea u osteoporosis y sarcopenia. Desde hace varios años estas condiciones clínicas en el adulto mayor han sido diagnosticadas y tratadas por separado, sin embargo, es claro que los mejores resultados se evidencian realizando diagnóstico e intervención en conjunto. En Colombia no existe información científica que estudie o describa este fenotipo en nuestra población de adultos mayores. Objetivo: El objetivo principal de esta revisión es realizar una descripción del fenotipo denominado osteosarcopenia, los mecanismos fisiopatológicos, factores de riesgo y las implicaciones clínicas de esta entidad en la población adulta mayor, así como describir lo que se conoce en la actualidad acerca de su diagnóstico, tratamiento e intervenciones. Metodología: se realizó una búsqueda no sistemática de la literatura en osteosarcopenia, osteoporosis, osteopenia y sarcopenia, incluyendo literatura acerca de la epidemiología, fisiopatología y diagnóstico. Resultados: la evidencia en osteosarcopenia es escasa, sin embargo, hay literatura creciente sobre el tema de interés, así como la relación de la osteoporisis y la sarcopenia por separado. Se logran reunir los conceptos más importantes de la actualidad. Conclusiones: A pesar del impacto que tiene esta condición en los pacientes y el sistema de salud, aún se encuentra en progreso la búsqueda e intervención simultánea y sistémica de la osteoporosis/osteopenia asociada a sarcopenia.

show abstract

Second Colombian Consensus on the Management of Post-menopausal Osteoporosis: 2017 update

Cited by 2 publications

References 165 publications

Impact of a Secondary Prevention Program for Fragility Fractures at the Orthogeriatric Clinical Care Center at the Fundación Santa Fe de Bogotá, 2014-2020

Impact of a Secondary Prevention Program for Fragility Fractures at the Orthogeriatric Clinical Care Center at the Fundación Santa Fe de Bogotá, 2014-2020

Osteosarcopenia en adultos mayores

Contact Info

Product

Resources

About